Total Payments
$9,530
2024 Payments
$120.60
Companies
32
Transactions
315
Medicare Patients
7,444
Medicare Billing
$512,222
Payment Breakdown by Category
Food & Beverage$8,001 (84.0%)
Travel$1,525 (16.0%)
Education$4.54 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,001 | 309 | 84.0% |
| Travel and Lodging | $1,525 | 5 | 16.0% |
| Education | $4.54 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,331 | 15 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $1,371 | 37 | $0 (2021) |
| Amgen Inc. | $746.24 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $719.49 | 40 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $584.42 | 29 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $438.40 | 31 | $0 (2019) |
| PFIZER INC. | $419.24 | 28 | $0 (2024) |
| Novo Nordisk Inc | $369.87 | 20 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $352.96 | 13 | $0 (2020) |
| Allergan, Inc. | $271.02 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $120.60 | 6 | Amgen Inc. ($44.36) |
| 2023 | $256.61 | 3 | Paratek Pharmaceuticals, Inc. ($121.41) |
| 2022 | $232.97 | 2 | Paratek Pharmaceuticals, Inc. ($119.94) |
| 2021 | $268.82 | 2 | Abbott Laboratories ($144.67) |
| 2020 | $1,563 | 49 | Boston Scientific Corporation ($589.34) |
| 2019 | $3,820 | 107 | Boston Scientific Corporation ($1,741) |
| 2018 | $2,275 | 95 | Novartis Pharmaceuticals Corporation ($345.58) |
| 2017 | $993.74 | 51 | Actelion Pharmaceuticals US, Inc. ($161.30) |
All Payment Transactions
315 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Cardiology | ||||||
| 06/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/15/2024 | AltaThera Pharmaceuticals LLC | Sotalol Hydrochloride (Drug) | Food and Beverage | Cash or cash equivalent | $10.98 | General |
| Category: Cardiovascular | ||||||
| 03/27/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/28/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $28.55 | General |
| Category: Cardiovascular | ||||||
| 02/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: Cardiology | ||||||
| 12/05/2023 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $20.23 | General |
| Category: Coronary | ||||||
| 02/15/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $121.41 | General |
| Category: ANTIBIOTIC | ||||||
| 02/03/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $114.97 | General |
| Category: Cardio-renal | ||||||
| 09/29/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $119.94 | General |
| Category: ANTIBIOTIC | ||||||
| 03/25/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $113.03 | General |
| Category: Cardio-renal | ||||||
| 12/02/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/28/2021 | Abbott Laboratories | MitraClip System (Device) | Food and Beverage | In-kind items and services | $144.67 | General |
| Category: Structural Heart | ||||||
| 10/28/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/22/2020 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Diabetes | ||||||
| 10/21/2020 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/20/2020 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $113.71 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/20/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/19/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/14/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: DIABETES | ||||||
| 10/14/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/08/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/06/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/30/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,322 | 1,444 | $408,172 | $61,624 |
| 2022 | 19 | 1,656 | 2,078 | $677,148 | $104,451 |
| 2021 | 21 | 1,921 | 2,422 | $546,325 | $131,977 |
| 2020 | 21 | 2,545 | 3,545 | $720,330 | $214,171 |
Total Patients
7,444
Total Services
9,489
Medicare Billing
$512,222
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 410 | 415 | $171,814 | $21,162 | 12.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 157 | 181 | $68,974 | $13,193 | 19.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 114 | 117 | $51,616 | $11,799 | 22.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 58 | 59 | $19,548 | $3,905 | 20.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 64 | $17,233 | $3,342 | 19.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 292 | 376 | $11,972 | $1,817 | 15.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $7,918 | $1,603 | 20.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 16 | $5,389 | $1,555 | 28.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 23 | 23 | $34,581 | $1,094 | 3.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 27 | 27 | $5,736 | $504.39 | 8.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 33 | 33 | $2,442 | $495.37 | 20.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 35 | 35 | $1,715 | $352.20 | 20.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 33 | 33 | $1,967 | $312.04 | 15.9% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Facility | 2023 | 13 | 13 | $1,092 | $244.55 | 22.4% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 15 | 15 | $2,790 | $138.00 | 4.9% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 14 | 14 | $756.00 | $79.80 | 10.6% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 11 | 11 | $2,629 | $27.06 | 1.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 298 | 524 | $200,900 | $50,905 | 25.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 210 | 211 | $178,076 | $12,258 | 6.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 104 | 134 | $35,702 | $8,103 | 22.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 57 | 58 | $23,828 | $6,709 | 28.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 520 | 651 | $54,810 | $4,571 | 8.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 30 | 30 | $11,231 | $4,420 | 39.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 14 | 14 | $10,649 | $3,308 | 31.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 42 | 43 | $96,501 | $2,860 | 3.0% |
About Dr. Bruce Watrous, M.D
Dr. Bruce Watrous, M.D is a Internal Medicine healthcare provider based in Wakefield, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609859958.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Watrous, M.D has received a total of $9,530 in payments from pharmaceutical and medical device companies, with $120.60 received in 2024. These payments were reported across 315 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($8,001).
As a Medicare-enrolled provider, Watrous has provided services to 7,444 Medicare beneficiaries, totaling 9,489 services with total Medicare billing of $512,222. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Wakefield, MA
- Active Since 11/21/2005
- Last Updated 06/20/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609859958
Products in Payments
- WATCHMAN (Device) $2,331
- XARELTO (Drug) $1,135
- ENTRESTO (Drug) $566.36
- Repatha (Biological) $534.34
- ELIQUIS (Drug) $420.89
- OPSUMIT MACITENTAN (Drug) $306.93
- BEVESPI AEROSPHERE (Drug) $296.89
- BRILINTA (Drug) $285.80
- VRAYLAR (Drug) $241.50
- NUZYRA (Drug) $241.35
- INVOKANA (Drug) $235.26
- Kerendia (Drug) $228.00
- Corlanor (Drug) $211.90
- CHANTIX (Drug) $199.93
- JARDIANCE (Drug) $158.15
- MitraClip System (Device) $144.67
- Tresiba (Drug) $121.91
- Cook Medical Zilver PTX (Device) $118.40
- NEXLIZET (Drug) $113.71
- PRALUENT ALIROCUMAB INJECTION (Biological) $113.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wakefield
Dr. James Rocco, M.d, M.D
Internal Medicine — Payments: $6,711
Internal Medicine $6,711
Monique Pouliot, D.o, D.O
Internal Medicine — Payments: $3,120
Internal Medicine $3,120
Dr. Nitin Damle, Md, MD
Internal Medicine — Payments: $3,102
Internal Medicine $3,102
Heidi Dorris, M.d, M.D
Internal Medicine — Payments: $3,009
Internal Medicine $3,009
Paul Barratt, M.d, M.D
Internal Medicine — Payments: $2,857
Internal Medicine $2,857
Dr. Griffin Reynolds, Md, MD
Internal Medicine — Payments: $2,808
Internal Medicine $2,808